Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome

Cancer Lett. 2008 Feb 18;260(1-2):72-8. doi: 10.1016/j.canlet.2007.10.028. Epub 2007 Dec 3.

Abstract

To determine whether human papillomaviruses (HPV) positive tonsillar squamous cell carcinoma (SCC) represent a specific entity, we studied the prevalence of HPV association and of tobacco/alcohol exposure in a series of 52 cases of tonsillar SCC cases. p53, p16, and pRb levels, deregulated by viral oncoproteins were assessed. Forty patients reported tobacco/alcohol exposure, 10 reported no exposure. HPV DNA was found in 32/52 (62%) cases, (HPV16 genotype in 27). All patients with no history of tobacco-alcohol exposure presented HPV positive tumor (p=0.0008). A strong correlation was observed between positive HPV status, decrease in pRB and increase in p16 expression level. 5 year overall survival rate was higher in HPV16 positive patients than in HPV negative (71% versus 36%; p=0.023). HPV status remained a significant prognostic factor in multivariate analysis. Tonsillar SCC can thus be divided in HPV positive and negative subgroups with different oncogenesis and response to treatment.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alcohol Drinking / adverse effects*
  • Carcinoma, Squamous Cell / chemistry
  • Carcinoma, Squamous Cell / etiology*
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy
  • Carcinoma, Squamous Cell / virology
  • Cyclin-Dependent Kinase Inhibitor p16 / analysis
  • DNA, Viral / analysis*
  • Female
  • Follow-Up Studies
  • Human papillomavirus 16 / genetics
  • Humans
  • Kaplan-Meier Estimate
  • Ki-67 Antigen / analysis
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Odds Ratio
  • Papillomaviridae / genetics*
  • Papillomavirus Infections / complications*
  • Papillomavirus Infections / virology
  • Phosphorylation
  • Prognosis
  • Retinoblastoma Protein / analysis
  • Risk Assessment
  • Risk Factors
  • Smoking / adverse effects*
  • Time Factors
  • Tonsillar Neoplasms / chemistry
  • Tonsillar Neoplasms / etiology*
  • Tonsillar Neoplasms / mortality
  • Tonsillar Neoplasms / pathology
  • Tonsillar Neoplasms / therapy
  • Tonsillar Neoplasms / virology
  • Tumor Suppressor Protein p53 / analysis

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA, Viral
  • Ki-67 Antigen
  • Retinoblastoma Protein
  • TP53 protein, human
  • Tumor Suppressor Protein p53